Given preliminary evidence for the beneficial effects of EPO on depression-relevant outcomes [8, 13], a secondary hypothesis is that add-on EPO treatment will produce greater, more sustained mood improvement than ECT treatment alone. This evidence concerns the gene EPO and major depressive disorder.